Brief: TELA Bio Q1 Revenue USD 18.52 Million Vs. IBES Estimate USD 17.4 Million
08/05/2025 21:05
May 08 (Reuters) - TELA Bio Q1 basic EPS USD -0.25. Q1 income from operations USD -10.472 million Q1 gross profit USD 12.512 million Q1 net income USD -11.264 million Q1 operating expenses USD 22.984 million outlook FY revenue USD 85-88 million
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants